Morten Schrøder

Board Member at Synklino

An experienced investor, business angel and board member in a range of mainly life science and medtech companies. Morten is also involved in MC2 Therapeutics, Mermaid Care, MEQU and XO Care.


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Synklino

1 followers

Synklino is a developer of a CMV-specific immunotoxin intended to eradicate the cytomegalovirus infection.


Headquarters

Lyngby, Denmark

Employees

11-50

Links